Elite Health Systems, Inc.

As of June 30, 2026, Elite Health Systems, Inc. carries a market capitalization of 28.81M, placing it among publicly traded companies globally. Its enterprise value stands at 27.52M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Elite Health Systems, Inc. has 28.52M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 6.89, and the price-to-book ratio stands at 11.21.

These figures are as of June 30, 2026. The EV/Sales ratio of 7.38 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 27.52M versus a market cap of 28.81M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Elite Health Systems, Inc. maintains a current ratio of 1.37, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Elite Health Systems, Inc. posted a negative return on equity (ROE) of -307.27, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -247.18, reflecting losses generated across the asset base. The company generates approximately 56,545.45 in revenue per employee across its workforce of 66.00, a quick read on workforce productivity versus industry peers.

As of the close on October 20, 2026, Elite Health Systems, Inc.'s stock has declined approximately 40.71% over the past 52 weeks. The 50-day moving average sits at 1.05, while the 200-day moving average is 1.06.

Over the twelve months ended June 30, 2026, Elite Health Systems, Inc. generated 3.73M in revenue and converted that into -9.76M in net income, yielding earnings per share of -0.38. EBITDA reached -5.98M, while operating income came in at -5.81M.

As of June 30, 2026, Elite Health Systems, Inc. holds 1.30M in cash and equivalents against 19,000.00 in total debt, resulting in a net debt position of -1.30M. Total book value stands at 2.57M, with working capital of 491,000.00 providing operational flexibility.

Elite Health Systems, Inc. produced -4.92M in operating cash flow over the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The operating margin of -155.60 and net profit margin of -261.66 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -19.13: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -11.83, meaning Elite Health Systems, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Elite Health Systems, Inc. has an Altman Z-Score of -6.55, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.